Αποτελέσματα Αναζήτησης
Summary of CDC STI Treatment Guidelines, 2021. commended regimens found in CDC’s Sexually Transmitted I. fections Treatment Guidelines, 2021. This summary is intended as a source of clinical guidance. When more than one therapeutic regimen is recommended, the sequence is in alphabeti.
These guidelines discuss 1) updated recommendations for treatment of Neisseria gonorrhoeae, Chlamydia trachomatis , and Trichomonas vaginalis ; 2) addition of metronidazole to the recommended treatment regimen for pelvic inflammatory disease; 3) alternative treatment options for bacterial vaginosis; 4) management of
This pocket guide reflects recommended regimens found in CDC’s Sexually Transmitted Infections Treatment Guidelines, 2021. This summary is intended as a source of clinical guidance.
These recommendations for the treatment of STIs reflect the 2015 CDC STI Treatment Guidelines; the focus is primarily on STIs encountered in outpatient practice. This table is intended as a source of clinical guidance and is not a comprehensive list of all effective regimens.
These guidelines for the treatment of persons who have or are at risk for sexually transmitted infections (STIs) were updated by CDC after consultation with professionals knowledgeable in the field of STIs who met in Atlanta, Georgia, June 11–14, 2019.
The use of updated and standardized STI management guidelines is strongly recommended in order to ensure standard quality treatment and prevention at all levels of health system. It also provides a clear guidance, facilitates training and supervision of healthcare providers, helps to improve surveillance, and assists in effective
The recommended treatment for uncomplicated gonococcal infection is ceftriaxone 500 mg intramuscular (IM) in a single dose, or 1 g IM in a single dose for persons weighing ≥150 kg.
